NCT00966914 2022-07-13Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus CisplatinBioNumerik Pharmaceuticals, Inc.Phase 3 Completed540 enrolled